|
| Press Releases |
|
 |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
| Monday, October 21, 2024 |
|
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area |
| China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") for qualified vitiligo patients were issued in the Greater Bay Area, at Zhongshan Chen Xinghai Hospital of Integrated Traditional Chinese and Western Medicine, Foshan Fosun Chancheng Hospital, and Dongguan Songshan Lake Tungwah Hospital. more info >> |
|
| Tuesday, September 24, 2024 |
|
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for vitiligo indication of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Friday, August 16, 2024 |
|
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023 |
| On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. more info >> |
|
| Monday, August 5, 2024 |
|
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 16, 2024 |
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating |
| In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development. more info >> |
|
| Tuesday, June 25, 2024 |
|
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
| On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
| more info >> |
|
| Tuesday, April 23, 2024 |
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets ("Desidustat Tablets" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY
Dec 19, 2024 15:35 HKT/SGT
|
|
|
Global Humanitarian Gurudev Sri Sri Ravi Shankar to Give Keynote Address at United Nations World Meditation Day, Followed by Live Global Meditation 
Dec 19, 2024 15:30 HKT/SGT
|
|
|
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
Dec 19, 2024 15:20 HKT/SGT
|
|
|
TechGALA 2025 - Aichi's First International Startup Conference
Dec 19, 2024 15:10 HKT/SGT
|
|
|
n-hop technologies Limited and OneAsia Network Limited Partner to Revolutionize Data Transfer and Networking Solutions
Dec 19, 2024 14:37 HKT/SGT
|
|
|
MI LNG Company to Change Corporate Name to MILES
Dec 19, 2024 13:49 JST
|
|
|
Two Honda 0 Series Prototype Models to Premiere at CES 2025
Dec 19, 2024 12:30 JST
|
|
|
Honda Presents World Premiere of Honda S+ Shift, Next-generation e:HEV Technology
Dec 19, 2024 12:13 JST
|
|
|
NEC Completes new Asia Pacific submarine cable
Dec 19, 2024 12:02 JST
|
|
|
Enablement of JCB Contactless Payment at All NJ TRANSIT Contactless Bus and Light Rail Validators in New Jersey, New York, and Pennsylvania
Dec 19, 2024 12:00 JST
|
|
|
American Wave Machines Announces Partnership with China Tourism Group
Dec 19, 2024 09:10 HKT/SGT
|
|
|
GENERALIFX Unveils Multimillion-Dollar AI Strategy Autopilot to Revolutionize Trading
Dec 19, 2024 08:50 HKT/SGT
|
|
|
Q2 Metals Announces Final Analytical Results from the 2024 Drill Campaign at the Cisco Lithium Property, James Bay, Quebec, Canada, and Proceeds of $1.9 Million from Warrant Exercises
Dec 19, 2024 08:40 HKT/SGT
|
|
|
Winvest Group Limited Stock Leaves the Pink And Makes the Leap to OTCQB
Dec 19, 2024 08:00 HKT/SGT
|
|
|
The finest places to live, work, and thrive in Asia are celebrated at the 19th PropertyGuru Asia Property Awards Grand Final
Dec 19, 2024 08:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
